breast implant clinical trials
The first documented attempt to increase (expand) the womb that happened 119 years ago. During the first 68 years, increased breast cancer has been attempted by injection direct materials, embedded in paraffin, grease and silicone free. These attempts have resulted in disastrous consequences, including infection, breast hard lumps, deformity, fat absorption, fat necrosis and chronic inflammatory reactions. Mine has been difficult, sometimes leading to such drastic measures as the mastectomy. After the invention of the mammogram, the injections have been found to create such artifacts that become more difficult the detection of cancer. For these reasons, direct injection of the breast have been abandoned by most plastic surgeons in the United States. No need for silicone injections in the chest for continuous increasing in many other countries in the late 20th century, however.
Breast implants commercially for the first time available in the U.S. in 1958, and more than 200 different types of implants and drawings have been made since then. Experts estimate that 60% of them had implants filled with silicone gel the exception of 1992-2006, when the FDA moratorium was in place. Implants Meanwhile, a saline-filled dominated the market. Dow Corning has dominated the market Implant First 30 years, but more than 15 other companies due to breast implants during the 1980s. Although Congress gave the authority of the FDA to regulate medical devices in 1976, breast implants are "bought in" and some products have undergone rigorous testing in clinical trials Pre open market sale. Regulation of breast implants took place in 1991 when the FDA has asked companies to submit applications for approval before marketing. Accordingly, the implant industry has taken 'blind' when the FDA has required global data with a period of 90 days for completion of all safety studies. With the attack at the same time thousands of lawsuits, implant manufacturers have been caught in a vise between the new FDA requirements, the chorus of "cookies" experts "claiming ties immune silicone, and the wave of litigation. Without good data to support the safety of silicone implants, the industry collapsed in less than three years. In 1992, the FDA banned the use of implants filled with silicone gel, not a protocol approved by the FDA for investigation because of concerns security. During the 1990s, all but two of the manufacturers of breast implants bankruptcy or stopped doing implants after breast implant litigation. In 1996, courts have appointed a National Scientific Committee, which examined more than 2,000 medical documents and heard testimony from legal experts, physicians and scientists. The Committee published its findings in 1998 concluding that there was no identifiable association between the use of silicone implants and disease. In 1999, the National Academy of Medicine Institute published a 455-page report which concluded that connective tissue diseases, cancer, other neurological or systemic complications are more common among women with breast implants than in women without implants. In 2006, the FDA lifted the moratorium on implants filled with silicone gel, if the two manufacturers still have post-approval studies involving 81,260 patients high for a period of 10 years 17 November 2006.
Today, most patients in the United States chose the silicone gel implants both for surgery cosmetic and reconstructive breast again but capsular contracture (hardening of the rates of breast cancer) are better today than in the 1960s, when the implants was first developed. In retrospect, capsular contracture is the main complication of the first attempt to increase in 1890 and remains the most important complication, breast augmentation in 2009. Despite this well-known fact, most of the attention given to implants with more than 119 years the period of implant rupture and unsubstantiated claims that implants cause systemic diseases in humans.
Current implants filled Silicone gel in the United States are what many call the "4th generation" implants, which are much more stringent manufacturing standards and testing standards. "5th generation" implants have been used in Europe for ten years and Canada for five years but not yet approved by the FDA. This generation "5" implants are cohesive gel implants commonly referred to as "gummy bear" implants. The advantages of these implants less runoff and lack of extrusion of gel / elastomer leak if the silicone shell breaks. There is much hope that these implants have a lower rate capsular contracture, but preliminary data indicate that the contracture is still a major problem, as all previous generations of implants.
We must learn the history of implants, silicone and not repeat history again. Good science should precede the trade and marketing. The cost of bringing a new implant market has grown exponentially due to FDA requirements and legal risk. But most of the new implants have been the first test in Europe or South America decades have been approved before the adoption in the United States. Many clinical trials are underway in the wide world of existing and new implants implants before the adoption of U.S. market obtained. Long-term studies remains to be done rupture rate of implants. Innovations must be made to reduce the most common complication, capsular contracture, which occurs today, after 119 years of history.
About the Author:
Dr. Mai Brooks is a surgical oncologist/general surgeon, with expertise in early detection and prevention of cancer. More at www.drbrooksmd.com, thecancerexperience.wordpress.com and progressreportoncancer.wordpress.com.
Article Source: ArticlesBase.com – History Of Breast Implants
Fat Graft Breast Augmentation & Reconstruction Leading Experts Miami Hand Center
